Français AA

Canadian Consortium on Neurodegeneration in Aging

The Canadian Consortium on Neurodegeneration in Aging (CCNA) provides the infrastructure and support that facilitates collaboration amongst Canada’s top dementia researchers. By accelerating the discovery, innovation, and the adoption of new knowledge, the CCNA positions Canada as a global leader in increasing understanding of neurodegenerative diseases, working towards prevention, and improving the quality of life of those living with dementia.


Hover over the infographic and click to learn more.

THEME 2
Treatment

Aims to improve diagnosis and treatment of dementia.
Research teams 7-13 are involved.

THEME 1
Prevention

Aims to identify the underlying mechanisms to prevent dementia.
Research teams 1-6 are involved.

THEME 3
Quality of Life

Aims to improve the management of dementia and the quality of life of those with lived experience.
Research teams 14-20 are involved.

National Platforms

National Platforms facilitate research and create opportunities for collaboration by pooling and drawing on big data.

1. Clinical Cohorts
2. The Normative Comparison Group
3. Imaging/ Database/ Information Technology
4. Biosamples
5. DNA Sequencing & Genotyping
6. Brain Banking
7. Transgenic Colonies
8. Academic Clinical Trials & Drug Development

Cross Cutting Programs

Cross Cutting Programs support the work of CCNA's 20 teams, and accelerate idea uptake.

Women, Gender, Sex & Dementia
Ensures that relevant sex and gender research questions will be studied across the spectrum of neurodegeneration in both human and animal model studies.

Cross Cutting Programs

Cross Cutting Programs support the work of CCNA's 20 teams, and accelerate idea uptake.

Training & Capacity Building
Supports the next generation of research leaders in understanding and responding to age-related neurodegenerative conditions, and provides professional development opportunities.

Cross Cutting Programs

Cross Cutting Programs support the work of CCNA's 20 teams, and accelerate idea uptake.

Ethical, Legal & Social Issues
Develops projects that explore the ethical, legal, and social issues in neurodegenerative research, and consults CCNA researchers on these topics.

Cross Cutting Programs

Cross Cutting Programs support the work of CCNA's 20 teams, and accelerate idea uptake.

Knowledge Translation & Exchange
Accelerates the production and dissemination of knowledge for CCNA’s 20 research teams by tailoring findings for quick uptake by CCNA stakeholders.

350+ Canadian researchers and clinicians have come together to accelerate discovery in research on age-related neurodegenerative diseases.


CCNA on Twitter